Survival analysis revealed that higher expression levels of ASAP1-IT1, RMDN2-AS1, and TP53TG5-6 were associated with a poor prognosis in HCC patients, suggesting their utility as prognostic biomarkers. Here, RMDN2 is linked to hepatocellular carcinoma.